Octreotide-induced severe paradoxical hyperglycemia and bradycardia during subtotal pancreatectomy for congenital hyperinsulinism in an infant.
Batra
Yatindra Kumar
YK
Rajeev
Subramanyam
S
Samra
Tanvir
T
Rao
Katragadda L N
KL
D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects*; D001919:Bradycardia / Q000139:chemically induced*; D044903:Congenital Hyperinsulinism / Q000188:drug therapy*; D006801:Humans; D006943:Hyperglycemia / Q000139:chemically induced*; D007223:Infant; D016343:Monitoring, Intraoperative; D015282:Octreotide / Q000009:adverse effects*; D010180:Pancreatectomy; D013997:Time Factors
D018931:Antineoplastic Agents, Hormonal; D015282:Octreotide